BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 6389731)

  • 1. [The changes in antibody dependent cell-mediated cytotoxicity (ADCC) in cancer patients during radiotherapy--estimation by plaque assay].
    Ichiyanagi A
    Nihon Gan Chiryo Gakkai Shi; 1984 Jun; 19(5):1032-40. PubMed ID: 6389731
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody-dependent cellular cytotoxicity in blood monocytes and alveolar macrophages in patients with lung cancer.
    McLennan G; Gill PG; De Young NJ
    J Natl Cancer Inst; 1985 Jul; 75(1):23-7. PubMed ID: 3859693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective antibody-dependent tumour cell lysis by neutrophils from cancer patients.
    Dallegri F; Ballestrero A; Ottonello L; Patrone F
    Clin Exp Immunol; 1989 Jul; 77(1):58-61. PubMed ID: 2766579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of radiotherapy on the immunocompetence in patients with bronchogenic carcinoma and laryngeal cancer (author's transl)].
    Oshitani T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1981; 41(9):873-86. PubMed ID: 7335479
    [No Abstract]   [Full Text] [Related]  

  • 5. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
    Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S
    Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of antibody-dependent cellular cytotoxicity (ADCC) by normal and pathological sera from patients with advanced lung cancer.
    Fekete B; Sachno L; Tamássy K; Pál A; Angyal I; Forrai I
    Haematologia (Budap); 1981 Dec; 14(4):417-23. PubMed ID: 7344976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of systemic chemotherapy on anti-P-glycoprotein antibody-dependent cell-mediated cytotoxicity in patients with small cell lung cancer.
    Nabioullin R; Yanagawa H; Haku T; Hiramatsu K; Yano S; Hanibuchi M; Pai K; Tsuruo T; Sone S
    Jpn J Clin Oncol; 1995 Aug; 25(4):124-30. PubMed ID: 7666588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressed lectin-dependent and enhanced antibody-dependent cell-mediated cytotoxicity in patients with stage I cancer of the larynx.
    Perl A; Repassy G; Gonzalez-Cabello R; Lang I; Gergely P
    Nat Immun Cell Growth Regul; 1986; 5(2):100-6. PubMed ID: 3487714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rehabilitation of laryngeal and lung cancer patients after radiation treatment].
    Strashinin AI; Gerasimiak VG; Vladimirova VA; Ivanova LV
    Med Radiol (Mosk); 1980 Aug; 25(8):24-9. PubMed ID: 7401970
    [No Abstract]   [Full Text] [Related]  

  • 10. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
    Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
    J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of cell-mediated effector mechanisms in lung cancer.
    Feo Figarella E; Morillo F; Blanca I; Bianco NE
    J Natl Cancer Inst; 1984 Jul; 73(1):1-6. PubMed ID: 6330420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibody-dependent cell-mediated cytotoxicity (ADCC) in gastric and colorectal cancer].
    Sekizuka H; Noro K; Haruyama S; Kiribuchi Y; Hayashi F
    Gan No Rinsho; 1986 Jul; 32(8):879-82. PubMed ID: 3747148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of concomitant pathology and radiation treatment on the immunity indices of patients with laryngeal cancer].
    Bulbuk GA; Tsybyrné GA; Mazur LN; Dariĭ VA
    Vopr Onkol; 1989; 35(5):608-12. PubMed ID: 2741432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytotoxic activity of large granular lymphocytes (LGL) infiltrated into metastatic tumors of lung cancer].
    Aoyagi Y; Takai K; Shibata A; Ishikawa H; Ohnishi Y
    Gan No Rinsho; 1984 Aug; 30(10):1241-6. PubMed ID: 6481960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte-mediated antibody-dependent cell-mediated cytotoxicity and spontaneous cytotoxicity in normals and cancer patients as assayed by human erythrocyte lysis.
    Bernhard MI; Pace RC; Unger SW; Wanebo HJ
    Cancer Res; 1983 Sep; 43(9):4504-10. PubMed ID: 6871879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plaque-forming cell (PFC) technique in the assay of serum blocking activity in lung cancer].
    Zhang XM
    Zhonghua Zhong Liu Za Zhi; 1985 Jul; 7(4):254-6. PubMed ID: 3910377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of synchronous-metachronous cancer of 3 visceral organs].
    Vazhenin AV; Mel'nikov DN
    Vopr Onkol; 1991; 37(5):609-12. PubMed ID: 1767519
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonspecific immunomodulating effects of BCG vaccine on antibody-dependent cell-mediated cytotoxicity.
    Koychev C; Guencheva G; Mihailova S; Engibarov A
    Dev Biol Stand; 1986; 58 ( Pt A)():389-93. PubMed ID: 3297873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of anti-D antibody dependent cell mediated cytotoxicity in patients with thyroid cancer.
    Szántó J; Léránth T
    Neoplasma; 1990; 37(2):167-72. PubMed ID: 2111522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flow-cytometric analysis of changes of lymphocyte subsets in the blood in cancer patients during radiotherapy. 5. Special reference to OKIa 1+-lymphocytes].
    Ogawa Y; Maeda T; Ogawa Y; Inomata T; Morita M; Yamamoto Y; Odani R; Yoshida S; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1984 Oct; 19(9):2138-45. PubMed ID: 6530582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.